Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study.
Attributions and self-efficacy for physical activity in multiple sclerosis.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies - Perspectives for immunoadsorption.
Auditory function in children with Charcot-Marie-Tooth disease.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study.
Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients.
Proteomic analysis for early neurodegenerative biomarker detection in an animal model.
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
Serial magnetic resonance imaging representation in a Baló's concentric sclerosis.
Does Nrf2 help nerves to survive?
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction.
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases.
VZV encephalitis that developed in an immunized patient during fingolimod therapy.
Why some of us do not like the expression "no evidence of disease activity" (NEDA) in multiple sclerosis.
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
Efficacy of gabapentin in the treatment of SUNCT syndrome.
Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.
Axon regeneration impediment: the role of paired immunoglobulin-like receptor B.
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.
Pages
« first
‹ previous
…
688
689
690
691
692
693
694
695
696
…
next ›
last »